Search

The isotope shifts in electron affinities of Pb were measured by Walter et al. [Phys. Rev. A 106, L010801 (2022)] to be −0.002(4) meV for 207–208Pb and −0.003(4) meV for 206–208Pb by scanning the threshold of the photodetachment channel Pb− ( S 3 / 2 ◦ 4 ) − Pb (3P0), while Chen and Ning reported 0.015(25) and −0.050(22) meV for the isotope shifts on the binding energies measured relative to 3P2 using the SEVI method [J. Chem. Phys. 145, 084303 (2016)]. Here we revisited these isotope shifts by using our second-generation SEVI spectrometer and obtained −0.001(15) meV for 207–208Pb and −0.001(14) meV for 206–208Pb, respectively. In order to aid the experiment by theory, we performed the first ab initio theoretical calculations of isotope shifts in electron affinities and binding energies of Pb, as well as the hyperfine structure of 207Pb−, by using the MCDHF and RCI methods. The isotope shifts in electron affinities of 207–208Pb and 206–208Pb are −0.0023(8) and −0.0037(13) meV for the 3P0 channel, respectively, in good agreement with Walter et al.'s measurements. The isotope shifts in binding energies relative to 3P1,2, −0.0015(8) and −0.0026(13) meV for 207–208Pb and 206–208Pb, respectively, are compatible with the present measurements. The hyperfine constant for the ground state of 207Pb− obtained by the present calculations, A ( S 3 / 2 ◦ 4 ) = − 1118 MHz, differs by a factor of 3 from the previous estimation by Bresteau et al. [J. Phys. B: At., Mol. Opt. Phys. 52, 065001 (2019)]. The reliability is supported by the good agreement between the theoretical and experimental hyperfine parameters of 209Bi. [ABSTRACT FROM AUTHOR]

The isotope shifts in electron affinities of Pb were measured by Walter et al. [Phys. Rev. A 106, L010801 (2022)] to be −0.002(4) meV for 207–208Pb and −0.003(4) meV for 206–208Pb by scanning the threshold of the photodetachment channel Pb− ( S 3 / 2 ◦ 4 ) − Pb (3P0), while Chen and Ning reported 0.015(25) and −0.050(22) meV for the isotope shifts on the binding energies measured relative to 3P2 using the SEVI method [J. Chem. Phys. 145, 084303 (2016)]. Here we revisited these isotope shifts by using our second-generation SEVI spectrometer and obtained −0.001(15) meV for 207–208Pb and −0.001(14) meV for 206–208Pb, respectively. In order to aid the experiment by theory, we performed the first ab initio theoretical calculations of isotope shifts in electron affinities and binding energies of Pb, as well as the hyperfine structure of 207Pb−, by using the MCDHF and RCI methods. The isotope shifts in electron affinities of 207–208Pb and 206–208Pb are −0.0023(8) and −0.0037(13) meV for the 3P0 channel, respectively, in good agreement with Walter et al.'s measurements. The isotope shifts in binding energies relative to 3P1,2, −0.0015(8) and −0.0026(13) meV for 207–208Pb and 206–208Pb, respectively, are compatible with the present measurements. The hyperfine constant for the ground state of 207Pb− obtained by the present calculations, A ( S 3 / 2 ◦ 4 ) = − 1118 MHz, differs by a factor of 3 from the previous estimation by Bresteau et al. [J. Phys. B: At., Mol. Opt. Phys. 52, 065001 (2019)]. The reliability is supported by the good agreement between the theoretical and experimental hyperfine parameters of 209Bi. [ABSTRACT FROM AUTHOR]

OBJECTIVE: This study evaluates the efficacy of statin-ezetimibe co-therapy compared to statin monotherapy in reducing cardiovascular and/or cerebrovascular disease (CVD) prevalence in diabetes and non-diabetes patients. PATIENTS AND METHODS: Literature search was conducted in electronic databases and study selection was based on pre-determined eligibility criteria. Random-effects metanalyses were performed to examine the risk of CVD incidence between statin-ezetimibe co-therapy and statin monotherapy and subgroups were performed to examine the significance of differences between diabetic and non-diabetic individuals. A pooled analysis of hazard ratios of statin-ezetimibe combination versus statin monotherapy in the prevalence of CVD reported by the individual studies was also performed. RESULTS: 8 studies (136893 individuals; 80790 diabetics, 85555 non-diabetics; age 63.5 years [95% confidence interval (CI) 61.2, 65.8]; 61.5% [95% CI 55.2, 67.8] males) were included. Follow-up duration was 45 months [95% CI 27.5, 62.5]. Risk of CVD prevalence was significantly less with ezetimibe-statin than with statin alone in both diabetes (RR 0.69 [95% CI 0.67, 0.73]; p<0.00001) and in non-diabetes (RR 0.68 [95% CI 0.52, 0.90]; p=0.006) subjects (subgroup difference: chi2=0.00; p=0.97). Risk of prevalence of stroke was significantly less with ezetimibe-statin than with statin monotherapy in diabetes (RR 0.74 [95% CI 0.56, 0.98]; p=0.03) but non-significantly less in non-diabetes patients (RR 0.74 [95% CI 0.39, 1.41]; p=0.39) and this sub-group difference was also not statistically significant (chi2=0.00; p=0.99). CONCLUSIONS: Statin-ezetimibe co-therapy is found more efficacious than statin monotherapy in reducing the incidence of CVD with no significant difference between diabetic and non-diabetic individuals. [ABSTRACT FROM AUTHOR]

Changes in the concentrations of trans-resveratrol (Res) and other phenolic compounds in the skin and seeds of red grape (Vitis vinifera x V. amurensis 'Beiquan') during low temperature storage (-1° ± 0.5°C) after post-harvest UV-B and UV-C irradiation and incubation at room temperature (25°C) were evaluated. No obvious changes in Res levels were observed in control and UV-B-irradiated grape skins after 14 d. A higher content of Res was recorded in UV-B- irradiated grape skins for only 7 d in cold storage, but the content was highest in UV-C-irradiated grape skins for the entire period (28 d) in cold storage. Total levels of anthocyanins in grape skins after either UV treatment were significantly higher than in controls during the first 7 d of storage, while only those in UV-B-treated skins were significantly higher than controls during the later period (from 21 -28 d) of storage, due to sharp declines in levels of the five main anthocyanins in UV-C-treated grape skins. Total flavan-3-ol and flavonol contents remained constant in UV-B- and UV-C-treated grape skins during cold storage and did not differ from controls. Levels of Res in grape seeds remained constant and did not differ between UV treatments, or from controls, over 28 d of low temperature storage. However, the total flavan-3-ol and flavonol contents in control and UV-B-treated grape seeds declined from day-2 to day-28 of cold storage, while those of UV-C-treated grape seeds remained constant. Changes in catechin and epicatechin were responsible for the changes observed in total flavan-3-ols and flavonols during cold storage. [ABSTRACT FROM AUTHOR]

In this study, a distributed charge storage with GeO2 nanodots is demonstrated. The mean size and aerial density of the nanodots embedded in SiO2 are estimated to be about 5.5 nm and 4.3×1011 cm-2, respectively. The composition of the dots is also confirmed to be GeO2 by x-ray absorption near-edge structure analyses. A significant memory effect is observed through the electrical measurements. Under the low voltage operation of 5 V, the memory window is estimated to ∼0.45 V. Also, a physical model is proposed to demonstrate the charge storage effect through the interfacial traps of GeO2 nanodots. © 2004 American Institute of Physics. [ABSTRACT FROM AUTHOR]

Presents a correction to the article "Memory Effect of Oxide/SiC: O/Oxide Sandwiched Structures," published in the volume 84, 2004 issue of the periodical "Applied Physics Letters."

Objective: To explore the correlation between serum free triiodothyronine (FT3) and C-peptide-based insulin resistance index (HOMA2 IR-CP) in euthyroid adults. Methods: A cross-sectional study. The clinical data of euthyroid adult participants who underwent physical examination in the Second Medical Center of Chinese PLA General Hospital from January to December in 2019 were retrospectively analyzed. According to the HOMA2 IR-CP level, the participants were divided into HOMA2 IR-CP>2.18 group ( n =3 463) and HOMA2 IR-CP≤2.18 group ( n =8 204). Univariate Pearson correlation analysis and multivariate logistic regression analysis were used to analyze the correlation between FT3 and HOMA2 IR-CP. The interaction model was used to analyze the interaction between FT3 and related factors, and the dose-response relationship between continuity variable FT3 and HOMA2 IR-CP was explored by using restricted cubic spline plots. Results: A total of 11 667 euthyroid adult participants aged (50.7±10.0)years were recruited according to the inclusion and exclusion criteria, with 7 756 males and 3 911 females. The proportion of males, body mass index, systolic blood pressure, glycated hemoglobin A1c, fasting plasma glucose, triglyceride, hemoglobin, alanine aminotransferase and FT3 levels in HOMA2 IR-CP>2.18 group were significantly higher than those in HOMA2 IR-CP≤2.18 group (all P <0.05). The levels of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and free thyroxine in HOMA2 IR-CP>2.18 group were lower than those in HOMA2 IR-CP≤2.18 group (all P <0.001). Univariate Pearson correlation analysis showed that FT3 was associated with HOMA2 IR-CP ( r =0.21, P <0.001). Multivariate logistic regression analysis suggested an association between FT3 and HOMA2 IR-CP after adjusting for confounding factors( P for trend <0.001). Subgroup analysis showed an association between FT3 and HOMA2 IR-CP in different subgroups of gender, age and glucose metabolism status ( P for trend <0.05). Multiplication interaction analysis suggested that there was an interaction between FT3 and age ( P interaction <0.001). Restricted cubic spline model analysis demonstrated that the correlation between FT3 and HOMA2 IR-CP was linear ( P overall <0.001, P nonlinear =0.479). Conclusions: There is a correlation between serum FT3 and HOMA2 IR-CP in euthyroid adults. With the increase of FT3 level, insulin resistance increases gradually.

Objective: To investigate the correlation between serum C-peptide and in adult population, and establish the corresponding insulin values of serum C-peptide levels. Methods: Cross-sectional study. The clinical data of the adults who underwent physical examination in the Second Medical Center of PLA General Hospital from January 2017 to December 2021 were retrospectively included. The participants were divided into type 2 diabetes group, prediabetes group and normal plasma glucose group according to the diagnostic criteria for diabetes. The correlation between serum C-peptide and insulin was explored by Pearson correlation analysis, linear regression analysis, and nonlinear regression analysis, and the corresponding insulin values of serum C-peptide were established. Results: A total of 48 008 adults were enrolled, including 31 633 males (65.9%) and 16 375 females (34.1%), aged (50.1±9.9) years (18-89 years). There were 8 160 subjects (17.0%) with type 2 diabetes, 13 263 subjects (27.6%) with prediabetes, and 26 585 subjects (55.4%) with normal plasma glucose. The serum fasting C-peptide (FCP, M ( Q 1 , Q 3 )] of the three groups were 2.76(2.18, 3.47), 2.54(1.99, 3.21) and 2.18(1.71, 2.79)μg/L, respectively. The fasting insulin [FINS , M ( Q 1 , Q 3 )] of the three groups were 10.98(7.57, 16.09), 10.06(6.95, 14.47) and 8.43(5.86,12.12)mU/L, respectively. FCP was positively correlated with FINS ( r =0.82), and 2 h postprandial C-peptide (2 h CP) was positively correlated with 2 h postprandial insulin (2 h INS) ( r =0.84) (both P <0.001). FCP was linearly associated with FINS ( R 2 =0.68), and 2 h CP was linearly associated with 2 h INS ( R 2 =0.71) (both P <0.001). There was a power function correlation between FCP and FINS ( R 2 =0.74), and 2 h CP and 2 h INS ( R 2 =0.78) (both P <0.001). The results of the statistical analysis were similar in various glucose metabolism subgroups. Since the fitting degree of the power function model was higher than that of the linear model, the power function model was the best model. The power function equation was FINS=2.96×FCP 1.32 , and 2 h INS=1.64×(2 h CP) 1.60 , respectively. Multivariate linear regression analysis demonstrated that FCP was a related factor of FINS ( R 2 =0.70, P <0.001) and 2 h CP was a related factor of 2 h INS ( R 2 =0.73, P <0.001), after adjusting for related confounders. Conclusions: There was a power function correlation between FCP and FINS, 2 h CP and 2 h INS in adult population. The insulin values corresponding to C-peptide levels were established in the study.

Objective: To investigate the relationship between hemoglobin and serum uric acid in adults with various glucose metabolism status. Methods: The demographic data and biochemical indicators of the adult population who had received physical examination in the Second Medical Center of the PLA General Hospital from January 2018 to December 2021 were collected. The subjects were divided into two groups according to the level of serum uric acid: the normal uric acid group and the hyperuricemia group. The relationship between hemoglobin (stratified into four levels of Q 1 to Q 4 by the quartile) and serum uric acid was quantified by using Pearson correlation and logistic regression analysis. The effects of age and glucose metabolism status on the relationship between hemoglobin and serum uric acid were analyzed. Results: A total of 33 183 adults were enrolled with age (50.6±10.0) years. The level of hemoglobin in the normal uric acid group (142.61±14.24) g/L was significantly lower than that in the hyperuricemia group [(151.79±11.24) g/L, P <0.001]. Univariate Pearson correlation analysis showed that hemoglobin was positively associated with serum uric acid ( r =0.444, P <0.001). After adjusting for related confounding factors, multivariate logistic regression analysis showed that hemoglobin was associated with serum uric acid, and the OR values (95% CI ) of hemoglobin Q 2 to Q 4 group were 1.29 (1.13-1.48), 1.42 (1.24-1.62) and 1.51 (1.32-1.72), respectively ( P trend < 0.001) when compared with hemoglobin Q 1 group. Subgroup analysis and hierarchical interaction analysis suggested that with the increase of hemoglobin, the serum uric acid in the age<60 years subgroup, normal glucose subgroup and prediabetes subgroup increased gradually ( P trend < 0.05 and P interaction < 0.001). Conclusion: The association between hemoglobin and serum uric acid in adults is affected by age and glucose metabolism status.

Objective: To investigate the relationship between glycemic variability and glycosylated hemoglobin (HbA1c) level during follow-up in elderly male patients with type 2 diabetes. Methods: Retrospective cohort study. A total of 200 elderly male patients who received continuous glucose monitoring from January 2007 to January 2011 were recruited in the Second Medical Center of PLA General Hospital. The subjects were divided into two groups according to baseline mean amplitude of glycaemic excursion (MAGE) level, including MAGE <3.9 mmol/L group ( n =114) and MAGE ≥3.9 mmol/L group ( n =86). The correlation between baseline MAGE and mean HbA1c during follow-up were evaluated by univariate Pearson correlation analysis and multivariate linear regression analysis. Results: Baseline characteristics including age, body mass index, waist circumference, smoking, drinking, fasting blood glucose, blood lipid and blood pressure were comparable between MAGE <3.9 mmol/L group and MAGE ≥3.9 mmol/L group. The average follow-up period was 12.5 years. The mean HbA1c during follow-up in MAGE ≥3.9 mmol/L group was significantly higher than that in MAGE <3.9 mmol/L group (7.23%±0.72% vs. 6.91%±0.77%, t =-2.94, P =0.004). The proportion of mean HbA1c <7.0% during follow-up in MAGE ≥3.9 mmol/L group was 44.2% (38/86), which was significantly lower than that in MAGE <3.9 mmol/L group [60.5% (69/114), χ 2 =5.26, P =0.022]. In univariate analysis, MAGE at baseline was correlated with the mean HbA1c during follow-up ( r =0.306, P <0.001). Multivariate linear regression analysis suggested that the baseline MAGE remained an independent influential factor of mean HbA1c ( β =0.09, 95% CI : 0.03 to 0.15, P =0.006, R 2 =0.31) after several confounding factors were adjusted. Conclusions: With the increased glycemic variability at baseline, mean HbA1c level during follow-up is accordingly elevated. The glycemic variability at baseline is independently related to mean HbA1c level during follow-up in elderly male patients with type 2 diabetes.